Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Alphageneron Pharmaceuticals logo — Our seasoned team of biopharmaceutical executives, scientist...

Alphageneron Pharmaceuticals

Our seasoned team of biopharmaceutical executives, scientists and clinicians, are an integral element to our success.

Founded 2020 United States New York, United States 3 employees Biotechnology, Health and Wellness

General Information

Company Name Alphageneron Pharmaceuticals
Founded Year 2020
Location United States New York, United States +1
Employees 3
Industries Biotechnology, Health and Wellness
Social

Get notified when Alphageneron Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Alphageneron Pharmaceuticals

Alphageneron Pharmaceuticals is a biotechnology startup founded in 2020, with its headquarters in the United States. The company is focused on advancing Natural Killer Cell (“NK Cell”) immunotherapies for hematologic cancers, solid tumors, and viral infections, including COVID-19. With a seasoned team of biopharmaceutical executives, scientists, and clinicians in the United States and Europe, Alphageneron emphasizes the significance of experience in ensuring its success. The company's slogan underlines the critical role that its experienced team plays in achieving its goals, showcasing confidence in its leadership. As of now, there is no information available about the last investment or the last investment investors. Alphageneron Pharmaceuticals appears to be a promising player in the biopharmaceutical industry, leveraging expertise and focusing on innovative therapies for critical medical conditions. While details about its funding and investment activities are not immediately apparent, the company's focus on cutting-edge treatments and its experienced leadership team position it as a potential candidate for future investment opportunities.

Taxonomy: biopharmaceuticals, NK cell immunotherapies, clinical stage, hematologic cancers, solid tumors, viral infections, COVID-19, executives, scientists, clinicians, United States, Europe, experience, innovation

No funding data available for Alphageneron Pharmaceuticals yet.

Get notified when Alphageneron Pharmaceuticals raises funding

Alphageneron Pharmaceuticals Alternatives & Competitors

Alphageneron Pharmaceuticals vs
CARsgen Therapeutics
CARsgen Therapeutics China

Making Cancer Curable

IPO
87 employees
Alphageneron Pharmaceuticals vs
BioInno
BioInno

Empowering global biopharma with world-class cell culture and GMP production services.

Series A
Biopharma, Biotechnology
Alphageneron Pharmaceuticals vs
Viropro
Viropro

Viropro, a publicly traded company based in Nevada, specializes in the development of cell lines and...

Convertible Note
Biotechnology, Manufacturing

FAQ About Alphageneron Pharmaceuticals

Our seasoned team of biopharmaceutical executives, scientists and clinicians, are an integral element to our success.
Alphageneron Pharmaceuticals was founded in 2020.
Alphageneron Pharmaceuticals is headquartered in New York, United States.
Alphageneron Pharmaceuticals operates in the following industries: Biotechnology, Health and Wellness.
Alphageneron Pharmaceuticals has approximately 3 employees.
Top alternatives and competitors to Alphageneron Pharmaceuticals include CARsgen Therapeutics, BioInno, Viropro, 恒瑞源正(深圳)生物科技有限公司, GT Biopharma, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alphageneron Pharmaceuticals and CARsgen Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Alphageneron Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy